These results suggest that an elevated HDAC9 expression is involved in the etiology of stroke and CAD and that HDAC9 targeted inhibition is one of the strategies to prevent atherosclerosis although the mechanism underlying a promoting effect of increased HDAC9 expression on atherogenesis and vascular risk is vague [26]. Here, HDAC9 is linked to atherosclerosis.